1. Olivieri C, Raybaud H, Tonoyan L, Abid S, Marsault R, Chevalier M, Doglio A & Vincent-Bugnas S. (2020). Epstein-Barr virus-infected plasma cells in periodontitis lesions. Microbial Pathogenesis, 143, 104128. https://doi.org/10.1016/j.micpath.2020.104128.

2. Tonoyan L*, Friel R & O’Flaherty V. (2020). Mutation rate and efflux response of bacteria exposed to a novel antimicrobial iodo-thiocyanate complex. Journal of Global Antimicrobial Resistance, 22, 13-17. https://doi.org/10.1016/j.jgar.2019.12.007.

3. Tonoyan L*, Vincent-Bugnas S, Olivieri C & Doglio A. (2019). New viral facets in oral diseases: the EBV paradox. International Journal of Molecular Sciences, 20(23), 5861. https://doi.org/10.3390/ijms20235861.

4. Tonoyan L*, Fleming GTA, Friel R & O’Flaherty V. (2019). Continuous culture of Escherichia coli, under selective pressure by a novel antimicrobial complex, does not result in development of resistance. Scientific Reports, 9(1), 2401. http://doi.org/10.1038/s41598-019-38925-9.

5. Tonoyan L*, Boyd A, Fleming GTA, Friel R, Gately CM, Mc Cay PH & O’Flaherty V. (2018). In vitro comparative cytotoxicity study of a novel biocidal iodo-thiocyanate complex. Toxicology In Vitro, 50, 264-273. https://doi.org/10.1016/j.tiv.2018.03.014.

6. Tonoyan L*, Fleming GTA, Mc Cay PH, Friel R & O’Flaherty V. (2017). Antibacterial potential of an antimicrobial agent inspired by peroxidase-catalyzed systems. Frontiers in Microbiology, 8(680). https://doi.org/10.3389/fmicb.2017.00680.

7. Ghazaryan L, Tonoyan L, Al Shhab A, Soares MIM & Gillor O. (2014). The role of stress in colicin regulation. Archives of Microbiology, 196(11), 753–764. http://doi.org/10.1007/s00203-014-1017-8.